SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Madharry who wrote (69578)1/22/2022 5:33:13 PM
From: E_K_S1 Recommendation

Recommended By
petal

  Read Replies (2) of 78464
 
Moderna Stock Crashes – Losses Top $130 Billion, Stock Down 67% from Highs Last Year Following Lackluster COVID Vaccine Results
----------------------------------------------

Seems like there is significant 'specific' stock risk when a Pharma company's has only one main drug and fails to work on other variants.

I hold both MRK and PFE but have been peeling off shares (now at a 50% position from 2021) and have deployed those funds into ABBV, GILD & Royalty Pharma Plc Cl A (RPRX).

RPRX is a recent Buffet acquisition

Merck & Co. (MRK)Warren Buffett sold 100% of Berkshire Hathaway's remaining 9,157,192 shares of Merck in the third quarter, according to the company's 13-F filing. Seeking Alpha reports that Buffett bought Merck in the third quarter of 2020 as vaccines were the talk of the investing world. The selloff was part of a larger shuffling of Buffett's drug holdings, which took place throughout 2021.

Buffett also reduced Berkshire's stake in drugmakers AbbVie and Bristol-Myers Squibb while eliminating 100% of his small position in a Merck spinoff called Organon & Co., which deals in contraception and other women's health products.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News